Kidney, endocrine, and metabolic conditions are among the fastest-growing contributors to global disease burden, often co-existing and driving lifelong illness, disability, and early mortality. These conditions disproportionately affect vulnerable populations and are closely linked to cardiovascular disease.

CTC delivers integrated clinical trials and large-scale studies, generating evidence across prevention, treatment, and long-term care, including in rare Chronic Kidney Disease associated conditions like Calciphylaxis. Our work supports more effective and equitable care, with a strong emphasis on implementation and policy impact, and often spans multiple disease areas, reflecting the interconnected nature of metabolic conditions.

Our research is highly collaborative, involving researchers at the Heat and Health Research Centre and the Poche Centre for Indigenous Health, international research networks such as the International Society for Nephrology, national trial networks, like Australasian Kidney Trials Network, industry partners, public health agencies, health services, and consumers, to deliver research with global reach and relevance.

Neurological and mental health conditions are among the most consequential causes of disability, affecting quality of life, independence, and long-term health outcomes for individuals and families. More effective, evidence-based approaches are urgently needed across diagnosis, treatment, rehabilitation, and ongoing care.

CTC supports trials addressing dementia, cognitive decline, and broader mental health and neurological disorders. Our capability in robust design, advanced analytics, and multicentre delivery enables research in areas where outcomes are often heterogeneous and care pathways remain uncertain.

We collaborate with clinicians, health systems, and organisations such as the Brain and Mind Centre and the Matilda Centre to deliver studies that are feasible, scalable, and positioned to improve care for people living with neurological and mental health conditions.

Surgical procedures and complex interventions are central to modern healthcare yet assessing their safety, effectiveness, and value remains challenging due to variability in practice, skill-based delivery, surgeon experience, and patient populations.

Our Surgical, Device, and Complex Interventions Research focuses on both proof of principle studies for devices and new surgical procedures and designing pragmatic trials that reflect real-world clinical practice. We apply innovative surgical trials specific methods, including adaptive and platform trial designs, to generate high-quality evidence on outcomes, safety, and value. Our approach integrates clinical expertise with robust methodology and data systems to inform better surgical decision-making. We have substantial experience in delivering trials examining surgery versus no surgery, placebo surgical controls, surgery versus non-surgical treatment and various surgical versus surgical treatment comparisons.

We work closely with surgical networks, academic collaborators, health services, and industry partners to evaluate new procedures, devices, clinical pathways, and models of care pre-operatively, peri-operatively and post-operatively. These partnerships, including Surgical Outcomes Research Centre, Institute of Academic Surgery, and Cancer institute NSW, enable us to deliver research that is directly relevant to clinical practice and supports safe, effective innovation.

The health of newborns, children and adolescents shapes lifelong wellbeing, and future disease risk. Early life offers one of the greatest opportunities to change outcomes, yet many questions in paediatric care still require stronger evidence and more coordinated research.

CTC delivers trials that improve diagnosis, treatment, prevention, and supportive care across childhood and adolescent health. Our work is designed to answer questions that matter early in life and that can improve outcomes well beyond childhood. Our neonatal and paediatric research has changed care, reduced deaths and disability, and informed global evidence synthesis and policy. 

We work with paediatric and neonatal networks, families, clinicians, health systems, researchers including at the Centre for Child and Adolescent Health, and international collaborators to generate evidence that improves care at the stage of life where it can matter most.

Health systems face increasing pressure to deliver better care with finite resources, requiring evidence that not only identifies effective interventions, but ensures they can be adopted and sustained in practice. Learning health systems offer a pathway to continuously improve care through integration of research and routine practice.

CTC delivers research that strengthens health service delivery, implementation, and system performance. Our work evaluates models of care, health system interventions, and service redesign, generating evidence that supports adoption at scale and informs policy and funding decisions.

By embedding research within real-world settings and collaborating with health services, government, and partners including those at the Centre for Disability Research and Policy, we help ensure that evidence is applied effectively, improving care pathways, enhancing system efficiency, and delivering more equitable and sustainable healthcare.